Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Synthesis of neoglycosphingolipid from methoxyamino-functionalized ceramide.

Ishida J, Hinou H, Naruchi K, Nishimura S.

Bioorg Med Chem Lett. 2014 Feb 15;24(4):1197-200. doi: 10.1016/j.bmcl.2013.12.091. Epub 2013 Dec 29.

PMID:
24461288
3.

Glycosphingolipid synthesis employing a combination of recombinant glycosyltransferases and an endoglycoceramidase glycosynthase.

Rich JR, Cunningham AM, Gilbert M, Withers SG.

Chem Commun (Camb). 2011 Oct 14;47(38):10806-8. doi: 10.1039/c1cc13885e. Epub 2011 Aug 30.

PMID:
21879043
4.

A novel glycosphingolipid-degrading enzyme cleaves the linkage between the oligosaccharide and ceramide of neutral and acidic glycosphingolipids.

Ito M, Yamagata T.

J Biol Chem. 1986 Oct 25;261(30):14278-82. Erratum in: J Biol Chem 1987 Feb 5;262(4):1926.

5.
6.
7.

A novel endoglycoceramidase hydrolyzes oligogalactosylceramides to produce galactooligosaccharides and ceramides.

Ishibashi Y, Nakasone T, Kiyohara M, Horibata Y, Sakaguchi K, Hijikata A, Ichinose S, Omori A, Yasui Y, Imamura A, Ishida H, Kiso M, Okino N, Ito M.

J Biol Chem. 2007 Apr 13;282(15):11386-96. Epub 2007 Jan 23.

8.

Total synthesis and glycosidase inhibition of broussonetine I and J(2).

Zhao H, Kato A, Sato K, Jia YM, Yu CY.

J Org Chem. 2013 Aug 16;78(16):7896-902. doi: 10.1021/jo4010553. Epub 2013 Jul 29.

PMID:
23829312
9.

Gaining insight into the catalysis by GH20 lacto-N-biosidase using small molecule inhibitors and structural analysis.

Hattie M, Ito T, Debowski AW, Arakawa T, Katayama T, Yamamoto K, Fushinobu S, Stubbs KA.

Chem Commun (Camb). 2015 Oct 18;51(81):15008-11. doi: 10.1039/c5cc05494j.

PMID:
26312778
10.
11.

The multivalent effect in glycosidase inhibition: a new, rapidly emerging topic in glycoscience.

Compain P, Bodlenner A.

Chembiochem. 2014 Jun 16;15(9):1239-51. doi: 10.1002/cbic.201402026. Epub 2014 May 7. Review.

PMID:
24807298
12.

Preparation and characterization of EGCase I, applicable to the comprehensive analysis of GSLs, using a rhodococcal expression system.

Ishibashi Y, Kobayashi U, Hijikata A, Sakaguchi K, Goda HM, Tamura T, Okino N, Ito M.

J Lipid Res. 2012 Oct;53(10):2242-51. doi: 10.1194/jlr.D028951. Epub 2012 Jul 15.

13.

Cloning and expression of gene encoding a novel endoglycoceramidase of Rhodococcus sp. strain C9.

Sakaguchi K, Okino N, Sueyoshi N, Izu H, Ito M.

J Biochem. 2000 Jul;128(1):145-52.

14.

Synthesis of novel mono and bis-indole conduritol derivatives and their α/β-glycosidase inhibitory effects.

Çavdar H, Talaz O, Ekinci D.

Bioorg Med Chem Lett. 2012 Dec 15;22(24):7499-503. doi: 10.1016/j.bmcl.2012.10.038. Epub 2012 Oct 23.

PMID:
23137433
15.

Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli.

Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C.

J Exp Med. 1996 Mar 1;183(3):1037-44.

18.

Amino(hydroxymethyl)cyclopentanetriols, an emerging class of potent glycosidase inhibitors--Part I: Synthesis and evaluation of beta-D-pyranoside analogues in the manno, gluco, galacto, and GlcNAc series.

Kleban M, Hilgers P, Greul JN, Kugler RD, Li J, Picasso S, Vogel P, Jäger V.

Chembiochem. 2001 May 4;2(5):365-8. No abstract available.

PMID:
11828465
19.

Hydrophobic Interactions Contribute to Conformational Stabilization of Endoglycoceramidase II by Mechanism-Based Probes.

Ben Bdira F, Jiang J, Kallemeijn W, de Haan A, Florea BI, Bleijlevens B, Boot R, Overkleeft HS, Aerts JM, Ubbink M.

Biochemistry. 2016 Aug 30;55(34):4823-35. doi: 10.1021/acs.biochem.6b00363. Epub 2016 Aug 16.

PMID:
27455091
20.

Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase.

Wascholowski V, Giannis A.

Angew Chem Int Ed Engl. 2006 Jan 23;45(5):827-30. No abstract available.

PMID:
16365835

Supplemental Content

Support Center